Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now
Goldman Sachs analyst Salveen Richter says big pharma is shopping in China biotech as $440 billion in drugs lose patents. The post Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now appeared first on BeInCrypto.
Key Takeaways
- Goldman Sachs analyst Salveen Richter says big pharma is shopping in China biotech as $440 billion in drugs lose patents.
- The post Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now appeared first on BeInCrypto.
- Read the full article for additional context and details.
Summary generated by IndiCrypto from BeInCrypto. IndiCrypto is a news aggregator and does not provide investment advice. Read the original article for full context.
More in Web3
Bitcoin dips below $84,000 as oil jumps on Iranian tanker attacks
Bitcoin briefly broke under the level analysts flagged as the point where sellers take over. Oil and the dollar both climbed.
Bitcoin briefly slides below $84,000 as crypto long liquidations reach $487 million
Crypto liquidations amounted to $555.6 million over the past 24 hours, including $487.2 million in long positions, according to CoinGlass.
Will SpaceX's $40B Nvidia Bet Help or Hurt the Stock After a 16% Run?
SpaceX plans $40 billion in debt for Nvidia chips after a 16% five-day rally. Here is what it may mean for SPCX shares. The post Will SpaceX's $40B Nvidia Bet Help or Hurt the Stock After a 16% Run? appeared first on BeInCrypto.